(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and oxidopamine

(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide has been researched along with oxidopamine in 2 studies

Compound Research Comparison

Studies ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide)	Trials ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide)	Recent Studies (post-2010) ((e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide)	Studies (oxidopamine)	Trials (oxidopamine)	Recent Studies (post-2010) (oxidopamine)
85	0	65	8,630	6	2,407

Protein Interaction Comparison

Protein	Taxonomy	(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide (IC50)	oxidopamine (IC50)
Glyceraldehyde-3-phosphate dehydrogenase	Homo sapiens (human)		8
DNA repair protein RAD52 homolog	Homo sapiens (human)		0.779

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Allahtavakoli, M; Asadi-Shekaari, M; Esmaeli-Mahani, S; Nazeri, M; Razavinasab, M; Shabani, M; Shamsizadeh, A; Sheibani, V	1
Ding, F; Li, M; Tian, Y; Xu, Q; Zhang, M; Zhu, M	1

Other Studies

2 other study(ies) available for (e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide and oxidopamine

Article	Year
Pharmacological blockade of TRPV1 receptors modulates the effects of 6-OHDA on motor and cognitive functions in a rat model of Parkinson's disease. Fundamental & clinical pharmacology, 2013, Volume: 27, Issue:6 Topics: Acrylamides; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cognition; Disease Models, Animal; Male; Motor Activity; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; TRPV Cation Channels	2013
Sensation of TRPV1 via 5-hydroxytryptamine signaling modulates pain hypersensitivity in a 6-hydroxydopamine induced mice model of Parkinson's disease. Biochemical and biophysical research communications, 2020, 01-22, Volume: 521, Issue:4 Topics: Acrylamides; Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Hyperalgesia; Male; Mice, Inbred C57BL; Oxidopamine; Pain Threshold; Parkinson Disease; Piperidines; Receptors, Serotonin, 5-HT3; Serotonin; Signal Transduction; Trigeminal Caudal Nucleus; TRPV Cation Channels	2020

Article

Year

Pharmacological blockade of TRPV1 receptors modulates the effects of 6-OHDA on motor and cognitive functions in a rat model of Parkinson's disease.

Fundamental & clinical pharmacology, 2013, Volume: 27, Issue:6

Topics: Acrylamides; Animals; Bridged Bicyclo Compounds, Heterocyclic; Cognition; Disease Models, Animal; Male; Motor Activity; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; TRPV Cation Channels

2013

Sensation of TRPV1 via 5-hydroxytryptamine signaling modulates pain hypersensitivity in a 6-hydroxydopamine induced mice model of Parkinson's disease.

Biochemical and biophysical research communications, 2020, 01-22, Volume: 521, Issue:4

Topics: Acrylamides; Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Hyperalgesia; Male; Mice, Inbred C57BL; Oxidopamine; Pain Threshold; Parkinson Disease; Piperidines; Receptors, Serotonin, 5-HT3; Serotonin; Signal Transduction; Trigeminal Caudal Nucleus; TRPV Cation Channels

2020